BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23684754)

  • 1. Effects of exenatide on kidney function, adverse events, and clinical end points of kidney disease in type 2 diabetes.
    Tuttle KR; Heilmann C; Hoogwerf BJ; Brown C; Anderson PW
    Am J Kidney Dis; 2013 Aug; 62(2):396-8. PubMed ID: 23684754
    [No Abstract]   [Full Text] [Related]  

  • 2. Exenatide and rare adverse events.
    Ahmad SR; Swann J
    N Engl J Med; 2008 May; 358(18):1970-1; discussion 1971-2. PubMed ID: 18456920
    [No Abstract]   [Full Text] [Related]  

  • 3. Exenatide added to insulin. Beware the potentially serious adverse effects of exenatide.
    Prescrire Int; 2013 Jun; 22(139):151. PubMed ID: 23885352
    [No Abstract]   [Full Text] [Related]  

  • 4. Exenatide and renal failure.
    Ferrer-Garcia JC; Martinez-Chanza N; Tolosa-Torréns M; Sánchez-Juan C
    Diabet Med; 2010 Jun; 27(6):728-9. PubMed ID: 20546299
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute tubulointerstitial nephritis following treatment with exenatide.
    Nandakoban H; Furlong TJ; Flack JR
    Diabet Med; 2013 Jan; 30(1):123-5. PubMed ID: 22762797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exenatide-associated ischemic renal failure.
    Weise WJ; Sivanandy MS; Block CA; Comi RJ
    Diabetes Care; 2009 Feb; 32(2):e22-3. PubMed ID: 19171732
    [No Abstract]   [Full Text] [Related]  

  • 7. Exenatide-induced depression in a geriatric patient.
    Kohen I; Lester P
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):443-4. PubMed ID: 18383195
    [No Abstract]   [Full Text] [Related]  

  • 8. Exenatide and acute pancreatitis.
    Tripathy NR; Basha S; Jain R; Shetty S; Ramachandran A
    J Assoc Physicians India; 2008 Dec; 56():987-8. PubMed ID: 19322980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cohort study of acute pancreatitis in relation to exenatide use.
    Dore DD; Bloomgren GL; Wenten M; Hoffman C; Clifford CR; Quinn SG; Braun DK; Noel RA; Seeger JD
    Diabetes Obes Metab; 2011 Jun; 13(6):559-66. PubMed ID: 21320263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exenatide: excessive weight loss.
    Prescrire Int; 2011 Jan; 20(112):17. PubMed ID: 21462789
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute exenatide (Byetta) poisoning was not associated with significant hypoglycemia.
    Cohen V; Teperikidis E; Jellinek SP; Rose J
    Clin Toxicol (Phila); 2008 Apr; 46(4):346-7. PubMed ID: 17852164
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of renal impairment on the pharmacokinetics of exenatide.
    Linnebjerg H; Kothare PA; Park S; Mace K; Reddy S; Mitchell M; Lins R
    Br J Clin Pharmacol; 2007 Sep; 64(3):317-27. PubMed ID: 17425627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.
    Pinelli NR; Cha R; Brown MB; Jaber LA
    Ann Pharmacother; 2008 Nov; 42(11):1541-51. PubMed ID: 18957626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exenatide and rare adverse events.
    Cure P; Pileggi A; Alejandro R
    N Engl J Med; 2008 May; 358(18):1969-70; discussion 1971-2. PubMed ID: 18450614
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes.
    Fineman MS; Shen LZ; Taylor K; Kim DD; Baron AD
    Diabetes Metab Res Rev; 2004; 20(5):411-7. PubMed ID: 15343588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exenatide (Byetta) for type 2 diabetes.
    Med Lett Drugs Ther; 2005 Jun; 47(1210):45-6. PubMed ID: 15933616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic gastroparesis.
    Heine RJ; Brodows R
    N Engl J Med; 2007 Jul; 357(4):418; author reply 419-20. PubMed ID: 17652660
    [No Abstract]   [Full Text] [Related]  

  • 18. No clinical harm from a massive exenatide overdose: a short report.
    Krishnan L; Dhatariya K; Gerontitis D
    Clin Toxicol (Phila); 2013 Jan; 51(1):61. PubMed ID: 23228005
    [No Abstract]   [Full Text] [Related]  

  • 19. Review of the safety and efficacy of exenatide once weekly for the treatment of type 2 diabetes mellitus.
    Murphy CE
    Ann Pharmacother; 2012 Jun; 46(6):812-21. PubMed ID: 22669803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exenatide for once-weekly administration.
    Drug Ther Bull; 2012 Jul; 50(7):78-80. PubMed ID: 22789767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.